Quantcast

Latest GlaxoSmithKline PLC Stories

2014-08-26 16:28:30

- New first-in-class treatment option for this previously treated SAA patient population LONDON, Aug. 26, 2014 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the once-daily use of Promacta(®) (eltrombopag) in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST).(1) SAA is a blood disorder...

2014-08-21 08:35:46

CHICAGO, Aug. 21, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Hewlett-Packard (NYSE:HPQ-Free Report), IBM (NYSE:IBM-Free Report), Safe Bulkers, Inc. (NYSE:SB-Free Report), GlaxoSmithKline plc (NYSE:GSK-Free Report) and Frank's International N.V. (NYSE:FI-Free...

2014-08-20 16:25:21

LONDON, Aug. 20, 2014 /PRNewswire/ -- GlaxoSmithKline plc today announced that the FDA has approved Arnuity(TM) Ellipta(®) (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older. Arnuity is not indicated for relief of acute bronchospasm. The approved doses are Arnuity Ellipta 100mcg and 200mcg. Arnuity Ellipta is administered once daily via the dry...

2014-08-06 08:32:23

LONDON, Aug. 6, 2014 /PRNewswire/ -- LON-ReportbuyerReportbuyer.com has added a new market research report:Antibacterial Drugs Market (By Class and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019http://www.reportbuyer.com/pharma_healthcare/therapeutic/antibacterial_drugs_market_by_class_pipeline_analysis_global_industry_analysis_size_share_growth_trends_forecast_2013_2019.html Antibacterial Drugs Market (By Class - Aminoglycosides,...

2014-08-05 08:35:30

New site is filled with information, patient testimonials, easy-to-use tools and real-world tips for people affected by COPD RESEARCH TRIANGLE PARK, N.C., Aug. 5, 2014 /PRNewswire/ -- Today GlaxoSmithKline plc (LSE/NYSE: GSK) announced the launch of the redesigned COPD.com website, which provides disease education, interactive tools, tips and inspirational testimonials from patients living with chronic obstructive pulmonary disease (COPD), for an up-close and personal look at managing and...

2014-07-31 12:29:00

DUBLIN, July 31, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Parkinson's Disease Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Parkinson's disease is a progressive neurodegenerative disorder characterized by damage of dopaminergic neurons located in various parts of brain including the substantia nigra. This lowers the concentration of dopamine in the striatum. A decrease in dopamine levels by 80 percent...

2014-07-28 16:26:36

LONDON, July 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018https://www.reportbuyer.com/product/2225690/Global-Non-Hodgkin-Lymphoma-Therapeutics-Market-2014-2018.htmlAbout Non-Hodgkin Lymphoma (NHL) and its Diagnostic ProceduresNon-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances, the lymphocytes grow and die....

2014-07-28 16:25:09

LONDON, July 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Oral Hygiene Market 2014-2018 https://www.reportbuyer.com/product/1592848/Global-Oral-Hygiene-Market-2014-2018.html About Oral Hygiene There are many problems such as dental caries and tooth decay that affect the health of teeth. Treatment of such oral problems involves a high expenditure in case of further deterioration. The players in the Global Oral Hygiene market have been...

2014-07-24 16:26:21

No. 1 Prescribed Allergy Treatment Ingredient(1) to be Available OTC PARSIPPANY, N.J., July 24, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase® Allergy Relief (fluticasone propionate 50 mcg spray), containing the No. 1 prescribed allergy treatment ingredient(1), as an over-the-counter (OTC) treatment for temporary relief of the symptoms of hay fever or upper respiratory allergies.(2) Flonase®...

2014-06-15 08:21:04

LONDON, June 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Depression Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_depression_drugs_market_2014_2018.htmlTechNavio's analysts forecast the Global Depression Drugs market to grow at a CAGR of 2.49 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in the number of patients suffering from...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'